FTI Consulting
FCN
$154.46
-0.12%
FTI Consulting, Inc. is a global business advisory firm providing professional services across five segments: corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications, operating within the broader Industrials sector. The company is a recognized leader in complex restructuring, investigations, and disputes, serving a diverse client base across industries like construction, energy, financial institutions, and technology. The current investor narrative is shaped by a significant institutional bet on the stock amid recent price weakness, suggesting a view of potential undervaluation despite the company's record earnings, with attention focused on whether its advisory services are poised to benefit from economic volatility and increased regulatory and litigation activity.…
FCN
FTI Consulting
$154.46
Related headlines
Investment Opinion: Should I buy FCN Today?
Rating & Thesis: Hold. FCN presents a conflicted profile where solid fundamentals and attractive valuation are overshadowed by severe technical damage and negative momentum, warranting a neutral stance until clearer directional evidence emerges. This aligns with the limited analyst coverage which shows a recent downgrade to and reaffirmation of a Hold rating.
Supporting Evidence: The hold rating is supported by four key data points: 1) A compelling forward P/E of 12.96x suggests the stock is not overvalued if growth materializes. 2) Revenue growth remains positive at 10.71% YoY. 3) The company generates robust free cash flow of $166.58 million TTM. 4) The balance sheet is strong with a current ratio of 1.56 and low debt. However, these are counterbalanced by a 19.91% one-month price decline and net margin compression.
Risks & Conditions: The two biggest risks are a failure to arrest the technical downtrend and further margin erosion. This Hold rating would upgrade to a Buy if the stock establishes a base above its 52-week low and quarterly net margins stabilize above 7%. It would downgrade to a Sell if the price breaks decisively below $140.84 on high volume or if forward EPS estimates are revised downward significantly. Based on its forward P/E relative to its own history, the stock appears fairly valued to slightly undervalued, but this is contingent on the company delivering on growth expectations.
Sign up to view all
FCN 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The data presents a clear dichotomy: valuation and cash flow metrics suggest underlying value, while momentum and sentiment indicators scream caution. The forward P/E is attractive, but it is predicated on earnings growth that recent margin trends call into question. The stock appears to be in a phase of price discovery, searching for a fundamental catalyst to break the intense selling pressure. The stance would upgrade to bullish on a confirmed reversal above the $170-175 resistance zone with improving quarterly margins. It would turn bearish on a sustained break below $140 with accompanying negative earnings revisions.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on FTI Consulting's 12-month outlook, with a consensus price target around $200.80 and implied upside of +30.0% versus the current price.
Average Target
$200.80
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$124 - $201
Analyst target range
Analyst coverage appears limited with only one analyst providing estimates for EPS and revenue, indicating insufficient breadth for a robust consensus view; this limited coverage is typical for mid-cap firms and can lead to higher volatility and less efficient price discovery. The single analyst estimates revenue of $4.54 billion and EPS of $12.16 for the period, but without a published target price or rating distribution, we cannot calculate a consensus price target or implied upside; the institutional ratings data shows recent actions including a downgrade from Buy to Hold by Truist Securities in April 2025, followed by a reaffirmation of Hold in October 2025, suggesting a neutral to cautious stance among the few covering firms.
Bulls vs Bears: FCN Investment Factors
The investment debate for FCN centers on a clash between deteriorating price momentum and a fundamentally sound, cash-generative business trading at a reasonable valuation. The bear case currently has stronger near-term evidence, driven by severe technical breakdowns, margin compression, and high short interest. However, the bull case is supported by strong free cash flow, a healthy balance sheet, and a forward P/E that prices in significant growth. The single most important tension is whether the recent institutional bet and low forward valuation correctly anticipate a fundamental rebound and earnings growth, or if the severe technical breakdown and margin volatility signal deeper, persistent operational challenges that the market is correctly pricing.
Bullish
- Strong Free Cash Flow Generation: The company generated $166.58 million in trailing twelve-month free cash flow, demonstrating its ability to fund operations and growth internally. This robust cash generation, coupled with a low debt-to-equity ratio of 0.34, provides a solid financial cushion and flexibility for strategic investments or shareholder returns.
- Attractive Forward Valuation: FCN trades at a forward P/E of 12.96x, a significant discount to its trailing P/E of 20.52x, implying the market expects substantial earnings growth. This forward multiple is also near the lower end of its historical P/E range (lows near 18x), suggesting a potential value opportunity if earnings estimates are met.
- Solid Balance Sheet & Profitability: The company maintains a healthy current ratio of 1.56 and an ROE of 15.62%, indicating efficient use of equity. Despite quarterly volatility, it remains profitable with a net margin of 7.15% and positive revenue growth of 10.71% YoY in Q4 2025.
- Institutional Confidence Amid Weakness: Recent news highlights a major institutional investor making a $183 million bet on FCN, signaling confidence in its upside potential despite the stock's 13% decline over the past year. This suggests sophisticated investors see the recent price weakness as a buying opportunity based on record earnings.
Bearish
- Severe Technical Downtrend & Underperformance: The stock is in a pronounced downtrend, down 19.91% over the past month and 13.01% over the past year, significantly underperforming the S&P 500 (up 25.19% over the past year). It is trading near its 52-week low of $140.84, indicating strong selling pressure and broken momentum that may persist.
- Volatile & Compressing Profit Margins: Net margin compressed from 8.66% in Q3 2025 to 5.5% in Q4 2025, highlighting significant quarterly volatility in profitability common in project-based consulting. Gross margin also declined sequentially from 33.25% to 31.05%, indicating potential pricing pressure or cost inefficiencies.
- Limited Analyst Coverage & Downgrade: Analyst coverage is sparse with only one firm providing estimates, leading to less efficient price discovery and higher volatility. The limited institutional ratings include a downgrade from Buy to Hold by Truist Securities in April 2025, reflecting a neutral-to-cautious stance among the few covering the stock.
- High Short Interest & Idiosyncratic Risk: A short ratio of 4.56 indicates significant bearish sentiment in the market. Furthermore, the stock's beta of 0.001 shows it has exhibited virtually no correlation to the market recently, suggesting its price action is driven by company-specific, idiosyncratic risks that are difficult to hedge.
FCN Technical Analysis
The prevailing price trend is a pronounced downtrend, with the stock down 13.01% over the past year and currently trading near the bottom of its 52-week range, at approximately 76% of the distance from its 52-week high of $189.3 to its low of $140.84, positioning it closer to its lows which may suggest a value opportunity but also indicates significant selling pressure and broken momentum. Recent momentum has been sharply negative and accelerating, with the stock down 19.91% over the past month and 11.70% over the past three months, a severe divergence from the broader market's gains (SPY up 5.6% and 8.42% over the same periods) as shown by the relative strength figures of -25.51 and -20.12, signaling intense underperformance and potential capitulation. Key technical support is the 52-week low of $140.84, with resistance at the recent high of $189.3; a breakdown below support could trigger further selling, while a hold and reversal would suggest the downtrend is exhausting, and the stock's beta of 0.001 indicates it has exhibited virtually no correlation to market volatility recently, which is unusual and may reflect idiosyncratic factors driving its price action.
Beta
0.00
0.00x market volatility
Max Drawdown
-23.1%
Largest decline past year
52-Week Range
$141-$189
Price range past year
Annual Return
-8.1%
Cumulative gain past year
| Period | FCN Return | S&P 500 |
|---|---|---|
| 1m | -15.5% | +4.6% |
| 3m | -4.8% | +8.3% |
| 6m | -5.8% | +12.5% |
| 1y | -8.1% | +25.0% |
| ytd | -9.3% | +8.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FCN Fundamental Analysis
Revenue growth remains positive but has shown some deceleration on a sequential quarterly basis; the most recent Q4 2025 revenue was $990.75 million, representing a 10.71% year-over-year increase, but this follows higher growth rates in prior quarters (e.g., Q3 2025 revenue of $956.17 million grew from a lower base), with the Corporate Finance segment being the largest driver at $423.19 million in the latest period. The company is profitable with a net income of $54.53 million in Q4 2025 and a gross margin of 31.05%, though net margin of 5.5% has compressed from the 8.66% seen in Q3 2025, indicating some quarterly volatility in profitability which is common in project-based consulting. Balance sheet health is solid with a low debt-to-equity ratio of 0.34 and a strong current ratio of 1.56, while the company generated robust free cash flow of $166.58 million on a trailing twelve-month basis and an ROE of 15.62%, demonstrating an ability to fund operations and growth internally without excessive leverage.
Quarterly Revenue
$990746000.0B
2025-12
Revenue YoY Growth
+0.10%
YoY Comparison
Gross Margin
+0.31%
Latest Quarter
Free Cash Flow
$166577000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FCN Overvalued?
Given a positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 20.52x and a forward PE of 12.96x; the significant discount of the forward multiple implies the market expects substantial earnings growth in the coming year. Compared to sector averages (data not explicitly provided in the input), we can infer from historical context that a trailing PE around 20x is below its own historical highs seen in late 2024 (e.g., 33.84x at 2024-12-31), suggesting the market is not pricing in overly optimistic expectations currently. Historically, the stock's own PE ratio has ranged from lows near 18x to highs above 34x over the past few years; at 20.52x, it is positioned toward the lower end of its historical band, which could indicate a value opportunity if the company's fundamentals remain intact, rather than pricing in fundamental deterioration.
PE
20.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 15x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: FCN faces risks from volatile profitability, as evidenced by net margin compressing from 8.66% to 5.5% between Q3 and Q4 2025. This project-based earnings volatility makes future income streams less predictable. While the balance sheet is strong with a D/E of 0.34, the company's valuation relies on achieving the forward EPS estimate of $12.16 to justify its forward P/E of 12.96x. A miss on these growth expectations could lead to multiple compression. Revenue concentration in the Corporate Finance segment (the largest contributor) also presents a risk if demand for restructuring and advisory services wanes during an economic upswing.
Market & Competitive Risks: The stock trades at a trailing P/E of 20.52x, which is below its own historical high of 33.84x but may still be at a premium to slower-growing industrial peers, creating valuation compression risk if growth decelerates. The stock's severe underperformance (relative strength of -25.51 over one month) indicates it is being aggressively sold off, potentially due to sector rotation away from cyclical industrials. The near-zero beta of 0.001 is highly unusual and suggests the stock is being traded on idiosyncratic news or sentiment, making it vulnerable to sharp, unpredictable moves unrelated to broader market trends.
Worst-Case Scenario: The worst-case scenario involves a continuation of the current downtrend catalyzed by a significant earnings miss in the next quarter, leading to a wave of analyst downgrades. This could trigger a breakdown below the key technical support at the 52-week low of $140.84. Given the stock's recent max drawdown of -23.14% and its current price of $143.76, a realistic downside could see it re-test and break below the $140 level, representing a potential loss of approximately -20% to -25% from the current price. High short interest could exacerbate the decline through a cascading sell-off.
FAQ
The key risks are: 1) Technical & Sentiment Risk: The stock is in a severe downtrend with a high short ratio (4.56), indicating persistent selling pressure and bearish sentiment that could continue. 2) Operational Risk: Profit margins are volatile, with net margin compressing from 8.66% to 5.5% last quarter, calling future earnings predictability into question. 3) Liquidity & Coverage Risk: With only one analyst providing estimates, the stock suffers from less efficient price discovery and can be prone to sharp moves on limited news. 4) Idiosyncratic Risk: A beta of 0.001 means the stock's moves are largely disconnected from the market, making it difficult to hedge and subject to unpredictable, company-specific developments.
The 12-month outlook presents three scenarios. The Base Case (55% probability) sees the stock trading between $155 and $175 as it consolidates and meets forward EPS estimates. The Bull Case (25% probability) targets a return to the 52-week high of $189.3 and beyond, driven by an earnings beat and renewed demand for its services. The Bear Case (20% probability) warns of a breakdown below the $140.84 support to the $130-$141 range if earnings disappoint. The most likely outcome is the Base Case, assuming the company executes steadily but without a major catalyst to reverse the powerful negative momentum in the near term.
Based on forward earnings, FCN appears fairly valued to slightly undervalued. Its forward P/E of 12.96x represents a significant discount to its trailing P/E of 20.52x and is near the lower end of its historical range (lows near 18x). This implies the market is not pricing in excessive optimism. Compared to sector peers, its valuation is likely reasonable given its growth profile and profitability. However, the valuation is contingent on the company hitting its forward EPS estimate of $12.16; any shortfall would make the stock look expensive quickly.
FCN is a speculative buy only for investors with a high risk tolerance and a value-oriented, contrarian mindset. The forward P/E of 12.96x and strong free cash flow generation suggest the stock is not overvalued fundamentally. However, with the price down nearly 20% in a month and trading near 52-week lows, the technical and sentiment picture is severely damaged. It could be a good buy for those who believe the institutional bet on record earnings is correct and that the current sell-off is an overreaction, but investors must be prepared for further volatility and have a long enough horizon to wait for a turnaround.
FCN is unsuitable for short-term trading due to its high volatility, negative momentum, and idiosyncratic price action (beta ~0). It is better suited for a long-term investment horizon of 2-3 years, allowing time for its fundamental value proposition—strong cash flow and reasonable growth—to outweigh the current technical and sentiment overhang. The lack of a dividend means investors are purely reliant on capital appreciation. Given the need for operational execution to stabilize margins and meet growth targets, a patient, long-term approach is required to realize the potential value implied by its forward valuation.